BlossomHill Therapeutics

Recent news

• Analysts Offer Insights on NA Companies: Expedia (EXPE) and BlossomHill Therapeutics, Inc. (BLSM)
  TipRanks · 2026/9/24
• Analysts Conflicted on These NA Names: Guardian Metal Resources PLC Sponsored ADR (GMTL), BlossomHill Therapeutics, Inc. (BLSM) and International Paper Co (IP)
  TipRanks · 2026/9/24
• Rating change
  J.P. Morgan Maintains BlossomHill Therapeutics(BLSM.US) With Buy Rating
  Market Newswire · 2026/9/18
• Rating change
  A Quick Look at Today's Ratings for BlossomHill Therapeutics(BLSM.US), With a Forecast Between $28 to $35
  Market Newswire · 2026/9/2
• Rating change
  Analysts Are Bullish on These NA Stocks: BlossomHill Therapeutics, Inc. (BLSM), Micron (MU)
  TipRanks · 2026/9/21
• J.P. Morgan Maintains BlossomHill Therapeutics(BLSM.US) With Buy Rating, Announces Target Price $30
  Market Newswire · 2026/9/24
• Leerink Partners Initiates BlossomHill Therapeutics(BLSM.US) With Buy Rating, Announces Target Price $40
  Market Newswire · 2026/9/22
• H.C. Wainwright Maintains BlossomHill Therapeutics(BLSM.US) With Buy Rating, Maintains Target Price $35
  Market Newswire · 2026/9/30
• Rating change
  Analysts Offer Insights on NA Companies: BlossomHill Therapeutics, Inc. (BLSM), Amrize Ltd (AMRZ) and ServiceTitan, Inc. Class A (TTAN)
  TipRanks · 2026/9/18
• Rating change
  LifeSci Capital Maintains BlossomHill Therapeutics(BLSM.US) With Buy Rating, Maintains Target Price $32
  Market Newswire · 2026/9/16

Headlines are aggregated automatically and are not independently verified or edited by our team.